Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
5AM Venture Management has fully exited its position in Dianthus Therapeutics, shedding 365,053 shares valued at $14.36 million. What does this mean for the biotech's future direction and market perception?